INOV.AM Agenda Promotes Portuguese Additive Manufacturing at Formnext 2025
The INOV.AM Agenda is making a prominent appearance at Formnext 2025, the leading international trade fair for additive manufacturing and 3D printing technologies, taking place from November 18-21 in Frankfurt, Germany. Representing the Agenda, AIDA CCI has organized the participation in a national collective stand, an initiative co-funded by the RRP – Recovery and Resilience Plan, with funds from the European Union – Next Generation EU.
A Showcase of Innovation for the National Industry
The main objective of this participation is to highlight Portugal‘s additive manufacturing ecosystem by presenting innovative solutions that strengthen the country’s position at the forefront of technological innovation, sustainability, and industrial competitiveness. The presence at Formnext 2025 represents a unique opportunity to bring together science, technology, and industry, promoting Portuguese potential to a specialized international audience.
An Ecosystem of Innovation in the Spotlight
The delegation organized by AIDA CCI includes a wide range of companies, research centers, and entities from the scientific and technological system, representing national excellence in this rapidly growing sector:
- Polytechnic University of Leiria (CDRSP)
- University of Minho
- Erofio, S.A.
- PTSCIENCE
- SOFAMOVEL
- GAMEIROS
- GLN
- LCR
- COBLEX
- Amorim Cork Composites
- MVC
- Sorgila SA
- MCS
- Vista Alegre
- SIVAL
- MENDES&RODRIGUES
- Movecho
- SCALESOCEAN
Invitation to Visit
We invite all attendees to visit the INOV.AM Agenda stand (Hall 11.0 | B81), where technological demonstrators showcasing the future of national additive manufacturing will be on display. This is an opportunity to get a close look at the potential of Portuguese companies and research centers and to explore synergies and partnerships.
The “INOV.AM Agenda” project runs from July 1, 2022, to June 30, 2026, and is one of the Mobilizing Agendas for Business Innovation supported by the RRP.
Learn More:
For more news, visit our news page.








